Abeona Therap (ABEO)
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It...
- Open
- 6.090
- High
- 6.695
- Low
- 6.050
- Prev. Close
- 7.460
- Volume
- 4.87M
- Turnover
- 31.11M
- Avg Price
- 6.383
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 8.65%
- 52wk High
- 7.650
- Volume Ratio
- 4.10
- Turnover Ratio
- 13.35%
Abeona Therap Analyst Rating
View moreForecast & Rating
Aug 13, 2026Price forecast
$19.57208.45%
Forecast & RatingStrong buy
6analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 16 hours ago
Abeona Therapeutics Q2 2026 Earnings Call Transcript
- Quartr · 17 hours ago
ABEO: Q2 2026 net revenue rose 31% to $11.4M as ZEVASKYN expanded to seven QTCs and gained NTAP status
- benzinga_article · 19 hours ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga_article · 20 hours ago
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
- Earnings Watch · 20 hours ago
Abeona Therap | 8-K: FY2026 Q2 Revenue: USD 11.38 M
- PUBT · Aug 6 at 06:31 AM
Abeona Therapeutics schedules conference call on Q2 2026 results
